Jacobs Levy Equity Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203K Buy
+130,020
New +$189K ﹤0.01% 918
2025
Q4
Sell
-692,727
Closed -$935K 1006
2025
Q3
$935K Buy
+692,727
New +$786K ﹤0.01% 734
2020
Q3
Sell
-219,311
Closed -$438K 1072
2020
Q2
$438K Sell
219,311
-186,827
-46% -$366K ﹤0.01% 815
2020
Q1
$792K Buy
406,138
+36,895
+10% +$110K 0.01% 681
2019
Q4
$1.53M Sell
369,243
-215,061
-37% -$828K 0.02% 592
2019
Q3
$1.76M Buy
584,304
+486,662
+498% +$1.51M 0.02% 538
2019
Q2
$614K Sell
97,642
-70,123
-42% -$420K 0.01% 710
2019
Q1
$933K Sell
167,765
-79,325
-32% -$482K 0.01% 678
2018
Q4
$1.64M Buy
247,090
+73,760
+43% +$598K 0.03% 503
2018
Q3
$1.85M Buy
173,330
+2,223
+1% +$25.5K 0.03% 536
2018
Q2
$2.05M Buy
171,107
+81,463
+91% +$833K 0.03% 506
2018
Q1
$768K Sell
89,644
-54,495
-38% -$504K 0.01% 694
2017
Q4
$1.42M Buy
+144,139
New +$1.5M 0.03% 540
2015
Q3
Sell
-28,054
Closed -$226K 844
2015
Q2
$226K Sell
28,054
-64,143
-70% -$471K ﹤0.01% 707
2015
Q1
$609K Sell
92,197
-68,951
-43% -$471K 0.01% 562
2014
Q4
$1.03M Buy
+161,148
New +$1.3M 0.02% 496

Other funds holding LXRX